Loading...
XASE
USBC
Market cap16mUSD
Jul 09, Last price  
0.33USD
1D
6.00%
1Q
7.42%
Jan 2017
-53.06%
IPO
-67.47%
Name

Know Labs Inc

Chart & Performance

D1W1MN
XASE:USBC chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
23.68%
Rev. gr., 5y
-48.31%
Revenues
0k
00002,542,6279,136,2167,923,9768,572,7997,983,3526,290,7946,023,6004,874,3594,303,2961,804,960121,93904,360,087000
Net income
-24.35b
L+146,773.60%
-1,032,036-1,634,993-945,066-950,609-1,148,920-2,409,756-2,731,898-6,621,894-1,017,281-2,631,037-1,746,495-3,901,232-3,257,597-7,612,316-13,562,641-25,360,213-20,071,244-15,289,167-16,581,558-24,353,931,000
CFO
-8m
L-40.79%
-770,493-317,4541645,120-440,968-1,312,291-58,174-3,503,580-1,379,397-239,877-3,373,734-1,264,324-1,117,131-3,104,035-3,913,803-6,850,699-6,919,808-10,353,991-12,829,350-7,595,708

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Know Labs, Inc., an American enterprise, is dedicated to the creation and market introduction of its proprietary technologies. At the heart of its operations is a technology known as Bio-RFID, which employs spectroscopy to transmit electromagnetic energy through substances or materials, thereby identifying and capturing their unique molecular signatures. This Bio-RFID system boasts adaptability, allowing for its incorporation into diverse form factors such as wearable devices, mobile applications, and stationary laboratory equipment. Its initial commercial offering leveraging Bio-RFID is a glucose monitoring product designed to furnish users with instantaneous data regarding their blood glucose concentrations. The company, initially named Visualant, Incorporated, officially adopted the name Know Labs, Inc. in May 2018. Established in 1998, Know Labs, Inc. operates from its headquarters in Seattle, Washington.
IPO date
Apr 12, 2006
Employees
15
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT